Cost‐effectiveness of dexamethasone and triamcinolone for the treatment of diabetic macular oedema in Finland: A Markov‐model

PURPOSE: Diabetic macular oedema (DMO), a complication of diabetes, causes vision loss and blindness. Corticosteroids are usually used as a second‐line treatment. The aim of this study was to analyse the cost‐effectiveness of dexamethasone implants compared to cheaper and more frequently applied tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Pesonen, Mari, Kankaanpää, Eila, Vottonen, Pasi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597173/
https://www.ncbi.nlm.nih.gov/pubmed/33421332
http://dx.doi.org/10.1111/aos.14745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597173/
https://www.ncbi.nlm.nih.gov/pubmed/33421332
http://dx.doi.org/10.1111/aos.14745

Ejemplares similares